van Bockel J H, van Schilfgaarde R, Felthuis W, Heidema J, van Brummelen P, Terpstra J L
Surgery. 1987 Apr;101(4):468-77.
This study assesses the late survival of 103 patients with renovascular hypertension caused by arteriosclerosis who underwent reconstructive surgery during the period of 1959 through 1982. It provides a detailed analysis of the influence of preoperative factors and the postoperative blood pressure response to fatal and nonfatal cardiovascular events during follow-up. All patients suffered from severe hypertension. Arteriosclerosis was limited to the renal arteries in 52% of the patients, while 48% showed overt extrarenal arteriosclerosis. Hypertensive target organ damage was present in 68% of the patients. At a mean of 8.5 months postoperatively, 80% of the patients showed beneficial and 20% showed unsatisfactory blood pressure responses. These results were not related to the presence or absence of extrarenal arteriosclerosis. Overall, late (10 years) patient survival was significantly lower than the expected survival of a reference population (79% versus 92%; p less than 0.0001). Late patient survival was not influenced by the absence or presence of extrarenal arteriosclerosis (82% versus 82%) or target organ damage (83% versus 82%), but late survival was significantly better with beneficial (87%) than with unsatisfactory blood pressure responses (67%). This effect was especially conspicuous in the presence of extrarenal arteriosclerosis (88% versus 57%; p = 0.04) but not in its absence (86% versus 74%; p = 0.41). In terms of long-term survival, these findings clearly demonstrate the favorable effect of successful surgical treatment of patients with renovascular hypertension caused by arteriosclerosis. Moreover, they illustrate that the mere presence of preoperative extrarenal arteriosclerosis or target organ damage is not sufficient argument against surgical therapy.
本研究评估了1959年至1982年间接受血管重建手术的103例因动脉硬化导致肾血管性高血压患者的远期生存率。研究详细分析了术前因素的影响以及随访期间术后血压对致命和非致命心血管事件的反应。所有患者均患有重度高血压。52%的患者动脉硬化局限于肾动脉,而48%的患者有明显的肾外动脉硬化。68%的患者存在高血压靶器官损害。术后平均8.5个月时,80%的患者血压反应良好,20%的患者血压反应不理想。这些结果与肾外动脉硬化的有无无关。总体而言,患者的远期(10年)生存率显著低于参考人群的预期生存率(79%对92%;p<0.0001)。患者的远期生存率不受肾外动脉硬化的有无(82%对82%)或靶器官损害(83%对82%)的影响,但血压反应良好的患者远期生存率(87%)明显高于血压反应不理想的患者(67%)。这种效应在存在肾外动脉硬化的患者中尤为明显(88%对57%;p = 0.04),而在不存在肾外动脉硬化的患者中则不明显(86%对74%;p = 0.41)。就长期生存而言,这些发现清楚地证明了对因动脉硬化导致肾血管性高血压患者进行成功手术治疗的有利效果。此外,这些发现还表明,术前单纯存在肾外动脉硬化或靶器官损害不足以成为反对手术治疗的理由。